NASDAQ:IPCI - Nasdaq -
Intellipharmaceutics International Inc.
NASDAQ:IPCI (3/20/2019, 8:00:00 PM)
After market: 0.2151 +0 (+2.14%)0.2106
-0.06 (-22%)
The current stock price of IPCI is 0.2106 null. In the past month the price decreased by -44.58%. In the past year, price decreased by -96.49%.
Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.
Intellipharmaceutics International Inc.
30 WORCESTER ROAD
TORONTO A6 M9W 5X2
CEO: Isa Odidi
Phone: 416-798-3001
The current stock price of IPCI is 0.2106 null. The price decreased by -22% in the last trading session.
The exchange symbol of Intellipharmaceutics International Inc. is IPCI and it is listed on the Nasdaq exchange.
IPCI stock is listed on the Nasdaq exchange.
Intellipharmaceutics International Inc. (IPCI) has a market capitalization of 4.62M null. This makes IPCI a Nano Cap stock.
Intellipharmaceutics International Inc. (IPCI) has a resistance level at 0.33. Check the full technical report for a detailed analysis of IPCI support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IPCI does not pay a dividend.
Intellipharmaceutics International Inc. (IPCI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.89).
ChartMill assigns a fundamental rating of 2 / 10 to IPCI. IPCI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months IPCI reported a non-GAAP Earnings per Share(EPS) of -2.89. The EPS increased by 0.34% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -802.68% | ||
ROA | -119.81% | ||
ROE | -335.12% | ||
Debt/Equity | 0 |